Comments
Loading...
Immatics (IMTXW) Forecast
NewsEarningsImmatics (IMTXW) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestImmatics (NASDAQ:IMTXW) Stock Quotes, Forecast and News Summary
Immatics Stock (NASDAQ: IMTXW) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Immatics (IMTXW) stock?
You can purchase shares of Immatics (NASDAQ:IMTXW) through any online brokerage.
Who are Immatics (IMTXW) competitors?
Other companies in Immatics’s space includes: BeiGene (NASDAQ:ONC), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).
What is the forecast, or price target, for Immatics (IMTXW) stock?
There is no analysis for Immatics to provide a consensus price target.
What is the current price for Immatics (IMTXW)?
The stock price for Immatics (NASDAQ: IMTXW) is $0.05 last updated January 31, 2025 at 7:44 AM EST.
Does Immatics (IMTXW) pay a dividend?
There are no upcoming dividends for Immatics.
When is Immatics (NASDAQ:IMTXW) reporting earnings?
Immatics does not have any upcoming earnings scheduled.
Is Immatics (IMTXW) going to split?
There is no upcoming split for Immatics.
What sector and industry does Immatics (IMTXW) operate in?
Immatics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.